55 1.1. Epidémiologie de la prescription d'AVK 55 1.2. Validité de la mesure de l'INR capillaire chez les sujets âgés, p.57 ,
Annexe 1 : Document à destination du personnel soignant des EHPAD expliquant le déroulement de l'étude et le mode d', p.88 ,
Hemorrhagic Complications of Anticoagulant Treatment The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CHEST, pp.287-310, 2004. ,
Comité OMS d'experts de la standardisation biologique. Série de rapports techniques, p.687, 1983. ,
Antithrombotic and Thrombolytic Therapy for Valvular Disease, Chest, vol.141, issue.2, pp.576-600 ,
DOI : 10.1378/chest.11-2305
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278057
Les anticoagulants en France en 2012 : état des lieux et surveillance. ANSM ; 2012. http://ansm.sante.fr/Dossiers-thematiques/Anti-vitamine-K-AVK/Information-pour-les- professionnels-de-sante, Agence Nationale de Sécurité du Médicament et des produits de santé Effect of Study Setting on Anticoagulation Control: A Systematic Review and Metaregression. Chest, 2006. ,
History of drugs for thrombotic disease. Discovery, development, and directions for the future, Circulation, vol.89, issue.1, pp.432-481, 1994. ,
DOI : 10.1161/01.CIR.89.1.432
Studies of the hemorrhagic sweet clover disease : I. The preparation of hemorrhagic concentrates, The Journal of Biological Chemistry, vol.136, pp.47-55, 1940. ,
A preparation from spoiled sweet clover [3,3'-methylene- bis-(4-hydroxycoumarin)] which prolongs coagulation and prothrombin time of the blood: preliminary report of experimental and clinical studies, Proc Staff Meet, Mayo Clin, vol.16, pp.388-95, 1941. ,
The Discovery of Dicumarol and Its Sequels, Circulation, vol.19, issue.1, pp.97-107, 1959. ,
DOI : 10.1161/01.CIR.19.1.97
CLINICAL EXPERIENCE WITH WARFARIN (COUMADIN) SODIUM, A NEW ANTICOAGULANT, Journal of the American Medical Association, vol.159, issue.11 ,
DOI : 10.1001/jama.1955.02960280016004
Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin, Proceedings of the National Academy of Sciences, vol.71, issue.7, pp.2730-2733, 1974. ,
DOI : 10.1073/pnas.71.7.2730
Influence of CYP2C9 genotype on warfarin dose requirements???a systematic review and meta-analysis, European Journal of Clinical Pharmacology, vol.7, issue.4, pp.365-75, 2008. ,
DOI : 10.1007/s00228-008-0584-5
The risk of bleeding complications in patients with ,
Haplotypes on Transcriptional Regulation and Warfarin Dose, New England Journal of Medicine, vol.352, issue.22, pp.2285-93, 2005. ,
DOI : 10.1056/NEJMoa044503
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT), The Lancet, vol.348, issue.9025, pp.423-431, 1996. ,
DOI : 10.1016/S0140-6736(96)01109-9
The management of coumarin-induced over-anticoagulation. Annotation, British Journal of Haematology, vol.17, issue.1 ,
DOI : 10.1001/archinte.158.19.2136
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients Oral Anticoagulants vs Aspirin in Nonvalvular Atrial FibrillationAn Individual Patient Metaanalysis, Journal of Thrombosis and Haemostasis JAMA: the journal of the American Medical Association, vol.3288, issue.34, pp.692-696, 2002. ,
Protein C and the development of skin necrosis during anticoagulant therapy Necrosis of skin induced by coumarin in a patient deficient in protein S, Thrombosis and Haemostasis. British Medical Journal, vol.49298, issue.36668, pp.233-237, 1983. ,
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy), Thrombosis and Haemostasis, vol.78, issue.6, pp.1438-1481, 1997. ,
http://www.ansm.sante.fr/Dossiers-thematiques/Anti-vitamine-K-AVK/Information-pour-les- professionnels-de-sante/%28offset%29/2 [dernière consultation 30/05/2012] 33. Herreros-Herz M. Prévalence des patients sous antivitamine K en médecine générale, 2009. ,
Utilisation et suivi biologique des antivitamines K en pratique médicale courante. Résultats français de l'étude internationale ISAM chez des patients ayant une fibrillation auriculaire, pp.1797-803, 2006. ,
Les cliniques d'anticoagulants. Sang Thrombose Vaisseaux, pp.288-90, 2003. ,
The first anticoagulation clinic in France: organisation, promises and difficulties, 17th international congress on thrombosis, p.10, 2002. ,
AVK) en fonction du mode de surveillance : réseau spécialisé ou réseau conventionnel. Coordination : Pr Henri BOCCALON, Médecine vasculaire ? Pôle cardio-vasculaire et métabolique ? CHU Toulouse. [non publiée] 46 Comparaison de deux méthodes de gestion d'un traitement antivitamine K: clinique des anticoagulants (CAC) versus suivi conventionnel: étude randomisée de 1005 patients, Journal des Maladies Vasculaires, vol.32, pp.59-60, 2007. ,
An overview of the effect of computer-assisted management of anticoagulant therapy on the quality of anticoagulation, International Journal of Medical Informatics, vol.49, issue.3, pp.311-331, 1998. ,
DOI : 10.1016/S1386-5056(98)00087-2
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage, Journal of Thrombosis and Haemostasis, vol.69, issue.6, pp.935-978, 2008. ,
DOI : 10.1056/NEJM199507063330103
Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Archives of internal medicine, p.2509, 1989. ,
Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management, American Heart Journal, vol.132, issue.5, 1996. ,
DOI : 10.1016/S0002-8703(96)90040-X
Reliability of point-of-care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing, British Journal of Haematology, vol.889, issue.2, pp.370-375, 2002. ,
DOI : 10.1046/j.1365-2141.2001.02753.x
Precision and accuracy of point-of-care testing coagulometers used for self-testing and self-management of oral anticoagulation therapy, Journal of Thrombosis and Haemostasis, vol.97, issue.2 ,
DOI : 10.1111/j.1538-7836.2011.04568.x
Point of care testing for INR monitoring: where are we now?, British Journal of Haematology, vol.333, issue.4, pp.373-381, 2004. ,
DOI : 10.1023/A:1012734426811
Comparison of the quality of oral anticoagulant therapy through patient selfmanagement and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of internal medicine, pp.2639-2685, 2003. ,
Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease, Journal of Thrombosis and Thrombolysis, vol.5, issue.suppl, pp.19-24, 1998. ,
DOI : 10.1023/A:1013228718768
INR Self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial), Zeitschrift f??r Kardiologie, vol.10, issue.Suppl4, pp.118-142, 2001. ,
DOI : 10.1007/s003920170019
Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. The Annals of thoracic surgery, pp.1523-1530, 2001. ,
The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation, British Journal of Haematology, vol.26, issue.4, pp.557-64, 2004. ,
DOI : 10.1016/S0002-9343(98)00389-1
Self-Management of oral Anticoagulation in nonvalvular Atrial Fibrillation (SMAAF study) Zeitschrift für Kardiologie, pp.182-188, 2005. ,
A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin, Annals of Internal Medicine, vol.133, issue.9, pp.687-95, 2000. ,
DOI : 10.7326/0003-4819-133-9-200011070-00010
Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial, European Journal of Internal Medicine, vol.17, issue.4, pp.260-266, 2006. ,
DOI : 10.1016/j.ejim.2005.11.021
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison, The Lancet, vol.356, issue.9224, pp.97-102, 2000. ,
DOI : 10.1016/S0140-6736(00)02470-3
A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management, Journal of Clinical Pathology, vol.55, issue.11, pp.845-854, 2002. ,
DOI : 10.1136/jcp.55.11.845
Self management of oral anticoagulation: randomised trial, BMJ, vol.331, issue.7524, pp.10572639-10572685, 2005. ,
DOI : 10.1136/bmj.38618.580903.AE
Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring, British Journal of Haematology, vol.111, issue.2, pp.242-249, 2005. ,
DOI : 10.1038/sj.thj.6200249
Anticoagulation therapy home and office monitoring evaluation study, Journal of thrombosis and thrombolysis, vol.12, 2001. ,
A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>, JAMA, vol.281, issue.2, pp.145-50, 1999. ,
DOI : 10.1001/jama.281.2.145
Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis and Haemostasis, pp.1089-98, 2008. ,
A randomized trial of patient self-managed versus physician-managed oral anticoagulation, The Canadian Journal of Cardiology, vol.20, issue.11, pp.1117-1140, 2004. ,
Home prothrombin time monitoring after the initiation of warfarin therapy. Annals of internal medicine, pp.730-737, 1989. ,
Effect of Home Testing of International Normalized Ratio on Clinical Events, New England Journal of Medicine, vol.363, issue.17, pp.1608-1628, 2010. ,
DOI : 10.1056/NEJMoa1002617
Primary Prevention of Cardiovascular Diseases With Statin Therapy, Archives of Internal Medicine, vol.166, issue.21 ,
DOI : 10.1001/archinte.166.21.2307
Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. The Journal of heart valve disease, pp.518-543, 2011. ,
Comparing Point of Care International Normalised Ratio testing with laboratory testing methods in a cardiac inpatient population, Journal of Clinical Nursing, vol.119, issue.21-22 ,
DOI : 10.1111/j.1365-2702.2010.03357.x
Assessing agreement between point of care and pathology laboratory results for INR, Pathology, 2010. ,
Comparison of emergency department point-of-care international normalised ratio (INR) testing with laboratory-based testing, Emergency Medicine Journal, vol.28, issue.2, pp.155-164, 2010. ,
DOI : 10.1136/emj.2009.086520
members of the PoCT Management Committee. Point-of-care testing for patients with diabetes, hyperlipidaemia or coagulation disorders in the general practice setting: a systematic review ,
Patient satisfaction with point-of-care international normalized ratio testing and counseling in a community internal medicine practice. Managed care interface, pp.44-50, 2004. ,
Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants, Stroke, vol.40, issue.11, pp.3547-51, 2009. ,
DOI : 10.1161/STROKEAHA.109.562769
Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation, International Journal of Cardiology, vol.99, issue.1, pp.37-45, 2005. ,
DOI : 10.1016/j.ijcard.2003.11.008
http://www.ameli.fr/professionnels-de-sante/directeurs-de-laboratoires-d-analysesmedicales/vous-former-et-vous-informer/guide-des-references-juridiques-biologiemedicale .php [dernière consultation 22, pp.2001-198, 2011. ,
Diagnostics au chapitre 1er du titre Ier de la liste des produits et prestations remboursables prévue à l'article L. 165-1 du code de la sécurité sociale, J. O., vol.24, 2008. ,
INR chez les patients adultes traités par antivitamine K. En vue de la prise en charge par l'assurance maladie des dispositifs d'automesure de l'INR http://www.has-sante.fr/portail/jcms/c_745452/evaluation-de-lautosurveillance-de-linr-chez- les-patients-adultes-traites-par-antivitamines-k [dernière consultation 01, 2008. ,
Les résidents des établissements d'hébergement pour personnes âgées en, 2007. ,
Prevalence of Atrial Fibrillation and Association of Atrial Fibrillation with Prior and New Thromboembolic Stroke in Older Patients, Journal of the American Geriatrics Society, vol.323, issue.5, pp.521-524, 1996. ,
DOI : 10.1111/j.1532-5415.1996.tb01436.x
Venous thromboembolism in the elderly. A community-based perspective. Thrombosis and Haemostasis, pp.780-788, 2008. ,
People Aged Over 75 in Atrial Fibrillation on Warfarin: The Rate of Major Hemorrhage and Stroke in More Than 500 Patient-Years of Follow-Up, Journal of the American Geriatrics Society, vol.128, issue.4, pp.655-664, 2000. ,
DOI : 10.1111/j.1532-5415.2005.53215.x
Oral Anticoagulation Treatment in the Elderly, Archives of Internal Medicine, vol.160, issue.4, pp.470-478, 2000. ,
DOI : 10.1001/archinte.160.4.470
Italian Study on Complications of Oral Anticoagulant Therapy) Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding ,
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF), American Heart Journal, vol.151, issue.3, pp.713-722, 2006. ,
DOI : 10.1016/j.ahj.2005.04.017
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation, Journal of the American College of Cardiology, vol.57, issue.2, pp.173-80, 2011. ,
DOI : 10.1016/j.jacc.2010.09.024
Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation, Circulation, vol.124, issue.7 ,
DOI : 10.1161/CIRCULATIONAHA.110.007864
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Archives of internal medicine, pp.2125-2133, 2001. ,
Les pathologies des personnes âgées vivant en établissement. Études et résultats N° 494, 2006. ,
Factors affecting the maintenance dose of warfarin., Journal of Clinical Pathology, vol.45, issue.8, pp.704-710, 1992. ,
DOI : 10.1136/jcp.45.8.704
Use of warfarin in long-term care: a systematic review, BMC Geriatrics, vol.31, issue.19, p.14, 2012. ,
DOI : 10.1093/eurheartj/ehq278
Evaluation de la validité et de l'utilité d'un appareil d'automesure de l'INR capillaire en institution gériatrique ,
Importance of Device Evaluation for Point-of-Care Prothrombin Time International Normalized Ratio Testing Programs, Mayo Clinic Proceedings, vol.80, issue.2, pp.181-187, 2005. ,
DOI : 10.4065/80.2.181
Accuracy of a Portable Prothrombin Time Monitor (Coagucheck) in Patients on Chronic Oral Anticoagulant Therapy, Thrombosis Research, vol.100, issue.4, pp.279-86, 2000. ,
DOI : 10.1016/S0049-3848(00)00323-6
Dispositifs d'automesure de l'INR. IDS ; Paris, 2011. ,
Enquête sur les conditions de réalisation des prélèvements d'INR à domicile. Pile ou face ? Exercer, pp.4-9, 2011. ,
Recommandations-Variables-preanalytiques_69_722.html [dernière consultation 17, 2012. ,
A Noninvasive Method of Examination of the Hemostasis System, Bulletin of Experimental Biology and Medicine, vol.38, issue.5, pp.1-3, 2011. ,
DOI : 10.1007/s10517-011-1407-8
Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly, Journal of Blood Medicine, 2011. ,
DOI : 10.2147/JBM.S13544
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.10, 2011. ,
DOI : 10.1056/NEJMoa1009638
URL : https://hal.archives-ouvertes.fr/hal-01038111
???????????????????????????? N'hésitez pas à me faire part de vos commentaires ,